Login
Home
Charts
Search
Watchlist
Products

Gujarat Kidney & Super Speciality Ltd

GKSL·NSE
175.17-4.39%Tue, 22 Sept '26

Gujarat Kidney & Super Speciality Ltd

GKSL
NSE
175.17
-4.39%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,381Cr
Close
Close Price
175.17
Industry
Industry
Hospitals/Medical Services
PE
Price To Earnings
71.21
PS
Price To Sales
13.67
Revenue
Revenue
101Cr
Rev Gr TTM
Revenue Growth TTM
118.53%
PAT Gr TTM
PAT Growth TTM
36.88%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
912101513233134
Growth YoY
Revenue Growth YoY%
37.497.2212.7124.7
Expenses
ExpensesCr
57778162426
Operating Profit
Operating ProfitCr
55395768
OPM
OPM%
51.639.026.756.539.629.720.624.4
Other Income
Other IncomeCr
00000011
Interest Expense
Interest ExpenseCr
00000111
Depreciation
DepreciationCr
11111121
PBT
PBTCr
44274557
Tax
TaxCr
11021102
PAT
PATCr
33153455
Growth YoY
PAT Growth YoY%
-2.746.1263.2-1.5
NPM
NPM%
31.521.513.635.422.316.015.815.5
EPS
EPS
0.70.50.30.80.50.50.80.7
QuarterSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
912101513233134
Growth YoY
Revenue Growth YoY%
37.497.2212.7124.7
Expenses
ExpensesCr
57778162426
Operating Profit
Operating ProfitCr
55395768
OPM
OPM%
51.639.026.756.539.629.720.624.4
Other Income
Other IncomeCr
00000011
Interest Expense
Interest ExpenseCr
00000111
Depreciation
DepreciationCr
11111121
PBT
PBTCr
44274557
Tax
TaxCr
11021102
PAT
PATCr
33153455
Growth YoY
PAT Growth YoY%
-2.746.1263.2-1.5
NPM
NPM%
31.521.513.635.422.316.015.815.5
EPS
EPS
0.70.50.30.80.50.50.80.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
0054082101
Growth
Revenue Growth%
742.9103.8118.5
Expenses
ExpensesCr
003245574
Operating Profit
Operating ProfitCr
002172727
OPM
OPM%
40.941.132.926.4
Other Income
Other IncomeCr
101012
Interest Expense
Interest ExpenseCr
000122
Depreciation
DepreciationCr
100355
PBT
PBTCr
002132121
Tax
TaxCr
001344
PAT
PATCr
002101717
Growth
PAT Growth%
-106.227,745.2454.277.036.9
NPM
NPM%
35.923.620.516.6
EPS
EPS
0.00.00.51.92.52.5
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
0054082101
Growth
Revenue Growth%
742.9103.8118.5
Expenses
ExpensesCr
003245574
Operating Profit
Operating ProfitCr
002172727
OPM
OPM%
40.941.132.926.4
Other Income
Other IncomeCr
101012
Interest Expense
Interest ExpenseCr
000122
Depreciation
DepreciationCr
100355
PBT
PBTCr
002132121
Tax
TaxCr
001344
PAT
PATCr
002101717
Growth
PAT Growth%
-106.227,745.2454.277.036.9
NPM
NPM%
35.923.620.516.6
EPS
EPS
0.00.00.51.92.52.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0001116
Reserves
ReservesCr
00215237
Current Liabilities
Current LiabilitiesCr
4442228
Non Current Liabilities
Non Current LiabilitiesCr
005715
Total Liabilities
Total LiabilitiesCr
442155298
Current Assets
Current AssetsCr
11722105
Non Current Assets
Non Current AssetsCr
331434193
Total Assets
Total AssetsCr
442155298
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0001116
Reserves
ReservesCr
00215237
Current Liabilities
Current LiabilitiesCr
4442228
Non Current Liabilities
Non Current LiabilitiesCr
005715
Total Liabilities
Total LiabilitiesCr
442155298
Current Assets
Current AssetsCr
11722105
Non Current Assets
Non Current AssetsCr
331434193
Total Assets
Total AssetsCr
442155298

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
00114-4
Investing Cash Flow
Investing Cash FlowCr
000-18-214
Financing Cash Flow
Financing Cash FlowCr
0006228
Net Cash Flow
Net Cash FlowCr
001211
Free Cash Flow
Free Cash FlowCr
022
CFO To PAT
CFO To PAT%
0.0-1.670.8143.3-23.0
CFO To EBITDA
CFO To EBITDA%
0.0-1.662.282.2-14.3
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
00114-4
Investing Cash Flow
Investing Cash FlowCr
000-18-214
Financing Cash Flow
Financing Cash FlowCr
0006228
Net Cash Flow
Net Cash FlowCr
001211
Free Cash Flow
Free Cash FlowCr
022
CFO To PAT
CFO To PAT%
0.0-1.670.8143.3-23.0
CFO To EBITDA
CFO To EBITDA%
0.0-1.662.282.2-14.3

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7981,381
Price To Earnings
Price To Earnings
51.571.2
Price To Sales
Price To Sales
9.713.7
Price To Book
Price To Book
3.25.5
EV To EBITDA
EV To EBITDA
28.153.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
87.080.9
OPM
OPM%
40.941.132.926.4
NPM
NPM%
35.923.620.516.6
ROCE
ROCE%
36.3-1.730.739.28.68.6
ROE
ROE%
26.6-1.798.536.66.76.7
ROA
ROA%
2.6-0.28.317.25.75.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7981,381
Price To Earnings
Price To Earnings
51.571.2
Price To Sales
Price To Sales
9.713.7
Price To Book
Price To Book
3.25.5
EV To EBITDA
EV To EBITDA
28.153.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
87.080.9
OPM
OPM%
40.941.132.926.4
NPM
NPM%
35.923.620.516.6
ROCE
ROCE%
36.3-1.730.739.28.68.6
ROE
ROE%
26.6-1.798.536.66.76.7
ROA
ROA%
2.6-0.28.317.25.75.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Gujarat Kidney & Super Speciality Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/6e4lqkj5v2kkvex1ebfpq652.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/krd7gpji65jqri85xegimit4.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/0dcg0so0cigrm3dpdow2ar1c.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/kap23w71139eb24pjm4kg2sg.pdf